From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Lynne S Taylor und 1 weiteren Autor:innen. Beteiligte Einrichtung: Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Drug Delivery Systems. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 131 Literaturangaben.
Abstract (Originalsprache)
The benefits and disadvantages of amorphous drugs have been topics of discussion for nearly a century. In the post-World War II era when drug discovery burgeoned, amorphous drugs were largely regarded as unfavorable forms for commercial products. This sentiment began to change as the number of poorly water-soluble drugs, which targeted a broader range of disease states and emerged from high throughput screening assays, began to increase. The solubility advantage of amorphous drugs was long recognized at this juncture, but unease persisted over potential conversions back to the less soluble crystal form during product storage. Successful development of early amorphous products based on amorphous solid dispersion formulations, where a suitable polymer is molecularly mixed with the drug resulting in inhibition of drug crystallization, gradually mitigated concerns. This historical perspective of amorphous drugs provides an overview of timelines and key milestones and culminates by considering remaining challenges and the future outlook.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, Indiana 47907, United States.
- School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
ORCID-Profile: Lynne S Taylor
Zitieren
APA
Taylor, L. S., & Zografi, G. (2025). From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00013
Vancouver
Taylor LS, Zografi G. From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00013
BibTeX
@article{Taylor2025,
author = {Taylor, Lynne S and Zografi, George},
title = {From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00013}
}
EUVIMED